10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543,000 | -33.5% | 37,395 | -10.0% | 0.01% | -22.2% |
| Q2 2023 | $2,319,000 | -9.2% | 41,538 | -9.2% | 0.01% | -18.2% |
| Q1 2023 | $2,553,000 | +48.5% | 45,752 | -3.0% | 0.01% | +57.1% |
| Q4 2022 | $1,719,000 | +30.7% | 47,173 | +2.1% | 0.01% | +16.7% |
| Q3 2022 | $1,315,000 | -35.8% | 46,183 | +2.0% | 0.01% | -33.3% |
| Q2 2022 | $2,049,000 | -38.7% | 45,279 | +3.1% | 0.01% | -25.0% |
| Q1 2022 | $3,342,000 | -50.7% | 43,933 | -3.5% | 0.01% | -47.8% |
| Q4 2021 | $6,778,000 | -0.3% | 45,504 | -2.5% | 0.02% | -4.2% |
| Q3 2021 | $6,797,000 | -27.3% | 46,686 | -2.2% | 0.02% | -27.3% |
| Q2 2021 | $9,348,000 | +69.3% | 47,737 | +56.5% | 0.03% | +50.0% |
| Q1 2021 | $5,521,000 | +38.2% | 30,501 | +8.1% | 0.02% | +22.2% |
| Q4 2020 | $3,996,000 | +41.6% | 28,219 | +24.7% | 0.02% | +20.0% |
| Q3 2020 | $2,822,000 | +52.3% | 22,630 | +9.0% | 0.02% | +36.4% |
| Q2 2020 | $1,853,000 | – | 20,752 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |